期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

宫颈高危型HPV感染后恶性转化及干预 被引量：2

Malignant conversion and prevention in cervix with high-risk HPV infection
暂未订购
导出
摘要 宫颈高危型人乳头瘤病毒 (HPV)感染是宫颈癌重要致病因素。研究宫颈细胞恶性转化中HPV的致癌作用 ,筛查、监测并干预宫颈高危型HPV感染 ,有利于宫颈癌及癌前损害的预防、诊断、治疗及预后 。
作者 孙瑞珍 郑茂荣 肖正达
机构地区 海军计划生育优生优育技术服务中心解放军第
出处 《国外医学（肿瘤学分册）》 2004年第4期303-305,共3页 Foreign Medical Sciences (Cancer Section)
关键词 HPV感染 宫颈癌 癌前损害 细胞转化 宫颈上皮内瘤样病变 分子生物学
分类号 R737.33 [医药卫生—肿瘤]
  • 相关文献

参考文献13

  • 1Kay P, Soeters R, Nevin J, et al. High prevalence of HPV 16 in South African women with cancer of the cervix and cervical intraepithelial neoplasia . J Med Virol, 2003, 71(2): 265-273.
  • 2Horn LC, Raptis G, Fischer U. Familial cancer history in patients with carcinoma of the cervix uteri. Eur J Obstet Gynecol Reprod Biol, 2002,101 (1): 54-57.
  • 3Dalstein V, Riethmuller D, Pretet JL, et al. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer, 2003,106(3): 396-403.
  • 4Cruickshank ME, Sharp L, Chambers G, et al. Persistent infection with human papillomavirus following the successful treatment of high grade cervical intraepithelial neoplasia. BJOG, 2002,109 ( 5 ): 579-581.
  • 5Furumoto H, Irahara M. Human papilloma virus (HPV) and cervical cancer. J Med Invest, 2002,49(3-4):124-133.
  • 6Filippova M, Song H, Connolly JL, et al. The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis. JBiol Chem, 2002, 277(24) :21730-21739.
  • 7Crum CP, Abbott DW, Quade BJ. Cervical cancer screening: from the papanicolaou smear to the vaccine era. J Clin Oncol, 2003, 21(90100): 224 - 230.
  • 8Eiben GL, da Silva DM, Fausch SC, et al. Cervical cancer vaccines: recent advances in HPV research. Viral Immunol, 2003,16(2): 111-121.
  • 9Knutson KL. Technology evaluation: T-cell activator, Xenova.Curr Opin Mol Ther, 2001,3(6): 585-588.
  • 10Simonart T, Boelaert JR, Mosselmans R, et al. Antiproliferative and apoptotic effects of iron chelators on human cervical carcinoma cells. Gynecol Oncol, 2002,85(1): 95-102.

同被引文献22

  • 1邹先进,蔡兰,刘颖,王梅,谢军花.子宫颈癌前病变与子宫颈癌组织中p16^(INK4A)蛋白检测及其与人乳头状瘤病毒感染的关系[J].中华妇产科杂志,2004,39(9):625-626. 被引量：25
  • 2Kamb A. A cell cycle regulator potentially involved in the genesis of many tumor type [J]. Science 1994,264:436-440.
  • 3Murphy N, Ring M, Killalea AG, et al. P16ink4A as a marker for cervical dyskaryosis: CIN and e GIN in cervical biopsies and Thinprep smears [J]. J Clin Pathol, 2003,5,6(1):56-63.
  • 4Nieh S, Chen SF, Chu TY, et al. Is P16 expression more useful titan human papillomavirus test to determine the outcome of atypical squamous cells of undermined significance-categorized Pap smears[J]. Gynecol oncol, 2005,97(1):35-40.
  • 5Dray M, Russell P, Dalrymple C. et al. P16ink4a as a complementary marker of high grade intraepithelial lesion of the uterine cervix, 1:experience with squamous lesion of the in 189 consecutive cervical biopsies. Pathology, 2005,37(2):112-124.
  • 6Adersson S, Rylander E, Larsson B, et al. The role of human papillomavirus in cervical carcinoma carcinogenesis. European Cancer, 2001,37:246-250.
  • 7Kanao H, Enomoto T, Ueda Y, et al. Correction between P14/P16ink4a expression and HPV infection in uterine cervical cancer. Cancer Lett, 2004,213( 1):31-37.
  • 8Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squsmous cell of undetermined significance: baseline results from a randomized trial. J Natt Cancer Inset, 2001,93:293-299.
  • 9Akpolat I, Smith DA, Ramzy I, et al. The utility of P16ink4a and cell block prepared from residual Thin -layer cervicovaginal material. Cancer, 2004,102(3): 142-149.
  • 10张小燕,丁晓萍,叶梅,徐海燕,卞美璐,陈庆云.莪术油对人乳头状瘤病毒的抑制作用[J].武警医学,2014,25(1):19-23. 被引量：21

引证文献2

二级引证文献3

国外医学（肿瘤学分册）
2004年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部